Is IMPZY or JNJ a better dividend investment in 2026?

IMPZY currently yields 1245.50% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: IMPZY offers higher current income.

What is the dividend yield difference between IMPZY and JNJ?

IMPZY has a forward dividend yield of 1245.50% ($1.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 1242.14 percentage points.

Home › Compare › IMPZY vs JNJ

IMPZY vs JNJ: Dividend Comparison 2026

IMPZY yields 1245.50% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IMPZY wins by $131031348.24M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IMPZY

● Live price

1245.50%

Share price

$0.08

Annual div

$1.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$131031348.26M

Annual income

$113,158,945,720,378.88

Full IMPZY calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — IMPZY vs JNJ

📍 IMPZY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IMPZY	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IMPZY + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IMPZY pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMPZY

Annual income on $10K today (after 15% tax)

$105,867.50/yr

After 10yr DRIP, annual income (after tax)

$96,185,103,862,322.05/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, IMPZY beats the other by $96,185,103,861,618.44/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMPZY + JNJ for your $10,000?

IMPZY: 50%JNJ: 50%

100% JNJ50/50100% IMPZY

Portfolio after 10yr

$65515674.14M

Annual income

$56,579,472,860,603.33/yr

Blended yield

86.36%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

IMPZY

No analyst data

Altman Z

4.6

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMPZY buys

JNJ buys

No recent congressional trades found for IMPZY or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIMPZYJNJ

Forward yield	1245.50% ✓	3.36%
Annual dividend / share	$1.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$131031348.26M ✓	$20.0K
Annual income after 10y	$113,158,945,720,378.88 ✓	$827.78
Total dividends collected	$129703763.91M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: IMPZY vs JNJ ($10,000, DRIP)

Year	IMPZY Portfolio	IMPZY Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$135,250	$124,550.00	$10,676	$355.77	+$124.6K → IMPZY
2	$1,719,053	$1,574,335.28	$11,407	$389.39	+$1.71M → IMPZY
3	$20,540,410	$18,701,024.00	$12,198	$426.53	+$20.53M → IMPZY
4	$230,812,388	$208,834,149.08	$13,056	$467.62	+$230.80M → IMPZY
5	$2,440,116,224	$2,193,146,968.85	$13,987	$513.12	+$2440.10M → IMPZY
6	$24,279,749,052	$21,668,824,691.91	$14,998	$563.56	+$24279.73M → IMPZY
7	$227,484,068,209	$201,504,736,723.12	$16,098	$619.52	+$227484.05M → IMPZY
8	$2,007,853,558,467	$1,764,445,605,483.42	$17,295	$681.69	+$2007853.54M → IMPZY
9	$16,703,179,945,996	$14,554,776,638,436.85	$18,599	$750.82	+$16703179.93M → IMPZY
10	$131,031,348,262,595	$113,158,945,720,378.88	$20,022	$827.78	+$131031348.24M → IMPZY

IMPZY vs JNJ: Complete Analysis 2026

IMPZY — Stock

Implanet S.A., together with its subsidiaries, researches and develops, manufactures, and sells spinal and orthopedic implants. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. The company also provides knee prostheses under the Madison name. Implanet S.A. has a strategic partnership with Shanghai Sanyou Medical Co, Ltd. The company was founded in 2006 and is based in Martillac, France.

Full IMPZY Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this IMPZY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMPZY vs SCHD IMPZY vs JEPI IMPZY vs O IMPZY vs KO IMPZY vs MAIN IMPZY vs ABBV IMPZY vs MRK IMPZY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.